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Delayed-type hypersensitivity (DTH)1 develops naturally in the course of many
infections (1) but is seldom a feature of artificial immunization unless the
antigen is given in a dose too small to provoke an antibody response (2-4), has
been chemically modified (5-7), or is administered in an emulsion containing
mycobacteria (8) . The state ofDTH produced without a mycobacterial adjuvant
is usually short-lived (3) and apt to disappear on renewed exposure to antigen, a
skin test dose of antigen being enough to abolish reactivity in some cases (9). The
DTH associated with infection, on the other hand, tends to be stable and long
lasting. It is virtually impossible, for example, to desensitize tuberculin-sensitive
guinea pigs by injections of old tuberculin (10). The DTH produced with
Freund's complete adjuvant (FCA) is similar, for it is difficult to abolish. It is
true that a large dose of antigen may cause a temporary depression ofDTH (10),
but reactivity soon returns (11).
The important quality of persistence thus seems to be characteristic of
naturally occurring forms ofcell-mediated immunity and those produced with an
adjuvant containing mycobacteria. This may be due, however, to persistence of
the antigenic stimulus itself. An active or latent infection, or a depot of
emulsified antigen, could serve to prolong the immune response and maintain the
production of specifically sensitized lymphocytes. The concept that a prolonged
immune response causes persistence ofDTH in animals immunized with antigen
in FCA (12) is supported by the finding that mediator cells are delivered to
thoracic duct lymph throughout a prolonged period of continuous drainage (13).
There is evidence, however, to support the opposing view that the cells which
mediate tuberculin sensitivity have a long life-span (14). This would allow them
to function for extended periods without the necessity for constant renewal.
Which of these alternatives explains the persistence of naturally occurring DTH
and what makes it resistant to desensitization? Can this stable and enduring
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form of DTH be produced by immunizing procedures that do not make use of
impractical adjuvants such as FCA? These questions have been examined in
mice which were immunized under the modulating influences ofcyclophospham-
ide (15) and BCG (16), which markedly enhance the T-cell response to sheep red
blood cells (SRBC).
Materials and Methods
Animals.
￿
Except when cell transfers were made, the mice used were specific pathogen-free mice
of the outbred CD-1 strain (Charles River Breeding Laboratories, Inc., Wilmington, Mass.). Adoptive
sensitization by spleen cell transfer was performed between syngeneic hosts. The strains used were
CH-TBF, 4 (Balb/c x CBA/H-T6) and B6H-T,F, q (C57BL/6 x CBA/H-T.) .
Antigen. SRBC from the same animal were obtained twice weekly. They were collected and
stored in Alsever's solution, and were washed three times before suspending to a known density in
normal saline.
BCG.
￿
The Pasteur strain of Mycobacterium bouis BCG (TMC 1011) was obtained from the
Trudeau Mycobacterial Collection (17). The organisms were grown as dispersed cultures in
Middlebrook's 7H9 medium containing Tween 80. After 5-7days incubation, the cultures were frozen
slowly to -70°C and were stored at this temperature (18) . Dosage was based upon viable counts
performed by plating on Middlebrook's 7H10 medium.
Immunization.
￿
Different routes and doses of SRBC were used for different purposes. But except
when specified, primary immunization was by intravenous or foot pad inoculation of 108 SRBC.
Modulation of the primary immune response was achieved with cyclophosphamide (CY) (donated by
Mead Johnson and Co., Evansville, Ind.) or by BCG. The drug, in a dose of 200kg/kg, was given 2
days before intravenous immunization and concurrently with subcutaneous immunization (15) .
BCG, on the other hand, was always injected 14 days before specific immunization with SRBC. Both
BCG (10' viable U) and SRBC (10') were given intravenously. Thesame timing was adhered to when
both agents were used to modulate the immune response. BCG was not used in these experiments to
modulate responses in peripheral lymphoid tissue (16, 19) . Secondary immunization was performed
in most instances by the intravenous injection of 108 SRBC .
Blocking Serum .
￿
Serum containing specific inhibitors of activated T cells was prepared from
mice bled 4 days after intravenous immunization with 108 SRBC . Its blocking activity was increased
by absorption with SRBC, as previously described (20) .
Test forDTH.
￿
DTH was measured in the right hind foot pad with an eliciting dose of 108 SRBC
(19).
Spleen cell transfer. Spleen cells for transfer to syngeneic recipients were prepared as in a
previous study (21) . The cells were pooled, washed three times, andenumerated in a hemacytometer.
Viability, as assessed by dye exclusion with trypan blue, was not less than 90%.
Vinblastine. Vinblastine sulfate (donated by Eli Lilly & Co., Indianapolis, Ind.) was freshly
dissolved in sterile saline. An intravenous dose of 100 kg was given 15-17 h before the harvesting of
spleen cells.
Results
Persistence of DZ'H afteran UnmodulatedPrimary Response.
￿
The DTH that
develops in response to intravenous immunization of mice with SRBC does not
persist for long, even after the optimum dose of antigen (4). Fig. 1 shows that the
time-course of the DTH generated by unmodulated responses to intravenous
immunization varies with dose of SRBC. The peak level of DTH increased as the
dose was raised from 103 to 105 SRBC; but at higher doses DTH decayed with
increasing rapidity, and could not be detected at any time in mice immunized84
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with 109 SRBC . A dose of 10' SRBC, which does not provoke an antibody
response (20), gave the highest persisting level of DTH at 24 days (Fig. 1) .
The Anamnestic Response after an Unmodulated Primary Response .
￿
Since
10' SRBC gave the highest sustained level of DTH after intravenous immuniza-
tion, this dose and route were used for both primary and secondary immuniza-
tion. The secondary stimulus was applied after 14 and 28 days. Fig. 2 A shows
that despite a significant level of DTH after the primary stimulus, animals failed
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Development and decay of DTH in groups of mice immunized intravenously with
varying doses of SRBC. Tests for DTH to SRBC were performed on the days indicated and
were read 24 h later. Means of 5.
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(A) Levels of DTH found in mice immunized intravenously with 10' SRBC (
￿
-
￿
)
and in mice which had received asecond (O---O) or third (A---A) dose of 10` SRBC 14 and 28
days after the primary stimulus . Means of 5. (B) Levels of DTH found in mice immunized
intravenously with 10' SRBC (* - *) and in a subgroup which received a secondary
intravenous stimulus of 10' SRBC 14 days after the primary stimulus ("---") . Means of 5 t
SEM.to respond to the second or third stimulus with any detectable rise in DTH; but
neither was there any loss of DTH. However, when the secondary dose of SRBC
was raised to a level (108) that caused rapid quenching of T-cell activity during
the primary response (Fig. 1), DTH disappeared completely (Fig. 2 B). This
confirms that the DTH resulting from minimal antigenic stimulation is abolished
by secondary immunization (9).
The Anamnestic Response after a Modulated Primary Response .
￿
CY raises
the level of DTH by delaying antibody production, thereby postponing the onset
of feedback inhibition ofthe T-cell response (15); BCG has asimilareffect, but it
is achieved without interfering with antibody production (16). It was important,
therefore, to observe the anamnestic T-cell responses of animals with residual
DTH resulting from sensitization under the modulating influence of CY, BCG, or
both .
Mice which had been treated with CY at the time ofsensitizing with a foot pad
inoculation of 108 SRBC had a DTH level of 9.8 when tested 21 days later (Fig. 3
A). At this time they were challenged intravenously with a secondary dose of 108
E
E
J J W
3 y
O
g
O a
x
N
14
12
10
8
8
4
2
P. H. LAGRANGE AND G. B. MACKANESS
￿
85
14
12
10
8
4
2
FIG. 3 .
￿
(A) Level ofDTHprevailing from day21 onward in mice which hadbeen treated with
CY and sensitized concurrently in the foot pad with 108 SRBC (* - *) . A secondary
intravenous stimulus of 108 SRBC (arrow) caused an immediate fall in DTH and asubsequent
trough of desensitization (A---A) . Control mice were not given the primary dose of SRBC; but
one group was treated with CY (O---O), the other was not (A---A) . Means of 5 t SEM. (B)
Level of DTH prevailing from day 21 onward in mice which hadbeen sensitized intravenously
with 108 SRBC 14 days after intravenous priming with 10' BCG (* - *) . A secondary
intravenous stimulus of 108 SRBC (arrow) caused immediate loss of DTH from which recovery
was prompt andpermanent (A . . . A). One group of controls received BCG butno primary dose
of SRBC (A---A), the other received only the secondary dose of SRBC (O---O) . Means of 5 t
SEM.86
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SRBC, a dose that erased the DTH resulting from an unmodulated primary
response (Fig . 2 B) . In this experiment it caused an immediate loss of DTH,
presumably because of temporary trapping of reactive cells in the spleen (22, 23),
and a phase of desensitization from which recovery was slow and incomplete (Fig.
3 A) .
In an experiment of similar design, mice were immunized intravenously with
108 SRBC 14 days after intravenous injection of 10' viable BCG. They had a
comparable level of DTH on day 21 (Fig. 3 B) . When challenged intravenously
with the same secondary dose (108) of SRBC, they also showed an immediate loss
and rapid recovery of DTH. But unlike the secondary response in mice with
CY-modulated immunity (Fig. 3 A), this one did not show a trough of
desensitization. Mice of one control group in the preceding experiment had been
given BCG but not the primary antigenic stimulus. They responded with a
modest enhancement of DTH in response to the secondary antigenic stimulus
(Fig. 3 B) . Since this was probably due to the modulating influence of the BCG
infection (now 5 wk old), tests for anamnestic responsiveness were performed in
the next experiment at 3 wk and again at 16 wk when the effects of BCG would
have long passed (16) .
In the next experiment, DTH was induced under the modulating influence of
both BCG and CY . Secondary antigenic stimuli were given at 3 and 16 wk . They
both provoked strong anamnestic responses (Fig. 4) which were devoid of the
episode of desensitization that characterized the anamnestic responses of
animals which had not been infected with BCG (Figs. 2 and 3 A) . It was
apparent, therefore, that DTH developed under the influence of BCG leaves the
capacity to respond to a secondary stimulus intact, but obviates the episode of
desensitization that normally accompanies it. In view of these findings, it became
necessary to test animals immunized in different ways for the presence or
absence of feedback inhibition during a secondary immune response. Since CY
had been shown to cause temporary abolition of feedback inhibition during a
primary response (15), it was used here in the expectation that it would have a
similar effect on the secondary response.
Influence of Feedback Inhibition on Anamnestic Responses.
￿
Two groups of
mice were prepared. Each possessed DTH resulting from a primary response to
108 SRBC . The primary response was modulated by CY in mice of one group and
by both BCG and CY in the other. Mice of both groups were subdivided 3 wk
later so that half of them could be given CY 2 days before the secondary antigenic
stimulus (108 SRBC), which was Also given intravenously .
The results in Fig. 5 A show that the animals in which the primary response
had been modulated only by CY again showed a phase of partial desensitization,
whereas those which received a second dose of CY 2 days before the secondary
antigenic stimulus showed only an acute and transient depression of DTH from
damage done by CY to the nonspecific accessory cells (monocytes) needed for the
expression of DTH (15) . Mice which had initially responded under the joint
influence of BCG and CY behaved quite differently (Fig. 5 B) . Although the
nonspecific effect of CY on accessory cells was again in evidence in the subgroup
which received the second dose of CY, the phase of desensitization, which is
immunologically specific (unpublished results), was absent in both groups . Thus,E
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Anamnestic T-cell responses in mice injected with 108 SRBC intravenously, 3 or 16
wk after primary intravenous immunization with 108 SRBC which was given under the
modulating influence of both BCG and CY (A . . . A) . The background level of DTH in the
absence of challenge remained almost constant throughout (. - .). Untreated control mice
received both primary andsecondary doses (O---O)or only the primary dose of SRBC ("-");
they were devoid of hypersensitivity . The lowlevels of DTH recorded in these controls reflect a
trend that occurs spontaneously as mice grow old. Means of 5 f SEM.
when the primary response occurred under the influence of BCG, CY had nothing
but a delaying influence on the secondary T-cell response. It seems, therefore,
that BCG-modulated immunity is not subject to feedback inhibition. If it were,
CY would have enhanced the T-cell response as it does during a primary response
(15) or the secondary response in CY-modulated immunity (Fig. 5 A) . This
finding focuses attention on the properties of the specifically sensitized lympho-
cytes created under the influence of BCG. Their longevity and susceptibility to
blocking by immune complexes become questions of immediate interest.
Properties of Specifically Sensitized Lymphocytes.
￿
Continuous production of
specifically sensitized lymphocytes was raised at the outset as a possible
explanation for the persistence of DTH after immunization with FCA. If the cells
that mediate DTH were produced continuously under the influence of BCG, they
would remain susceptible to a mitotic poison such as vinblastine (13, 24).
A transfer system was used to test the specific mediators of DTH for their
vulnerability to vinblastine because specifically sensitized lymphocytes are not88
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(A) Influence of CY on the anamnestic T-cell response of mice in which the primary
response had been modulated with CY to give ahigh andwell sustained level of DTH( . - *) .
When the secondary challenge of 108 SRBC was given (arrow) DTHlevels fell after challenge,
but rose steeply before the onset of a phase of partial desensitization (A-") . In mice given CY
(200 mg/kg) 2 days before challenge DTH wasrestored more rapidly and reached higher levels
than in unchallenged mice (A---A) . Means of 5 t SEM. (B) An experiment of similar design
was performed in mice in which primary immunization with 108 SRBC was modulated with
both BCG and CY. In this case CY given at the time of challenge did not potentiate the
secondary T-cell response, though it did cause a definite delay in its onset. Meansof5 f SEM.
the only relevant cells that are potentially susceptible to this drug (15, 25). Donor
mice were treated with CY 2 days before intravenous immunization with 108
SRBC. Groups of prospective donors were treated at intervals with vinblastine
and were sacrificed 15-17 h later for spleen cell transfer. An equal number of
untreated donors were used at each time point. Recipients were challenged
immediately after cell transfer with an eliciting dose of SRBC.
Fig. 6 shows the development of DTH in a group of animals immunized under
the influence of CY, and the level of DTH transferred to recipients by one spleen
equivalent of cells from similarly immunized donors which had or had not been
treated with vinblastine 15-17 h before cell transfer. Two distinguishable
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Susceptibility of specifically sensitized spleen cells to vinblastine. Donor mice (D)
were immunized intravenously with 108 SRBC 2 days after treatment with CY. Representa-
tives were tested for DTH at intervals during the next 28 days ("-") . At each time point one
spleen equivalent of cells were transferred to normal recipients (R) which were then tested for
DTH. Two groups of donors were used : one was untreated and the other was given
vinblastine (100 mg/mouse) 15-17 h before cell transfer. The levels of DTH are recorded for
recipients from untreated (O . . .O) andvinblastine-treated donors (A---A). Meansof 5 t SEM.
1 h before the transfers were made on days 4 and 15, five additional recipients were each given
0.2 ml of blocking serum (AS4). The DTH found in these mice is represented by the hatched
columns. Means of 5 t SEM.
populations of specifically sensitized lymphocytes were revealed : one, produced
during the first 8-10 days of the immune response, which was inactivated by
vinblastine; the other, which emerged more slowly, was not. Hence, the DTH
transferred by one spleen equivalent of cells harvested beyond day 10 of the
immune response was undiminished by treating the donors with vinblastine. In
the much more highly sensitized animals which had been immunized under the
joint influence of BCG and CY a similar pattern of susceptibility to vinblastine
was observed except that mediator cells remained sensitive to vinblastine over a
much longer period (Fig. 7) . In either case, the results indicate that sooner or
later DTH becomes vested in cells that cease to replicate. Since DTH persists
despite evidence that production of the mediators has ceased, the responsible
cells would be expected to survive well in syngeneic recipients.
The Life-Span of Specifically Sensitized Lymphocytes. Specifically sensi-
tized lymphocytes were transferred to syngeneic recipients from donors which
had been immunized with a view to producing a high level of hypersensitivity for
adoptive transfer, or to permit the behavior of replicating and resting cells to be
compared . In the first experiment donor mice were infected intravenously with
10' BCG Pasteur. After 12 days they were given CY and 2 days later they were
immunized intravenously with 109 SRBC . Animals immunized in this way have a
stable and high level of DTH by day 21 (reference 16 and Fig. 7) . The mean level
of DTH at this time in a representative group of five donors was 13.8 (Fig. 8) . The
level of DTH conferred with one spleen equivalent (about 2 x 10 8) of pooled90
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FIG. 7.
￿
In an experiment of similar design to that of Fig. 6, donor mice were immunized
intravenously with 109 SRBC after treatment with BCG and CY. Representative mice were
tested for DTH at intervals after immunization (* - *). At each time point one spleen
equivalent of cells from normal or vinblastine-treated donors were transferred to normal
recipients. The scale used to record the levels of DTH in recipients of untreated (" . . . ")
and vinblastine-treated spleen cells (A---A) is the same as that used in Fig. 6. Means of 5 t
SEM. On day5a separate group of recipients was given 0.2 ml of AS4 intravenously 1 hbefore
receiving sensitized cells from untreated donors. The level of hypersensitivity in these
recipients is depicted by the hatched bar. Mean of 5 t SEM.J
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FIG. 8 . The persistence of DTH was followed for a period of 30 days in mice immunized
adoptively with one spleen equivalent of cells from donors sensitized under the modulating
influence of both BCG and CY and used fortransfer on day 21 (") or modulated with CY and
used for transfer on day5 (") or day 14 ("). Corresponding symbolsareused to show thelevels
of DTH in the donors and recipients. Means of 5 t SEM.
spleen cells from these donors rose during the first 2 days after cell transfer . This
may reflect a continuing replication of mediator cells, as suggested by their
partial sensitivity to vinblastine at this time (Fig. 7) . After this initial period of
equilibration the level of sensitivity in recipients decayed slowly with an apparent
half-life of 34 days . A notable feature was the remarkably uniform level of DTH
found within the groups of five recipients tested at each time point.
In the second experiment two types of donors were used . Neither had received
BCG, thus avoiding the objection to the foregoing experiment that BCG would
have been transferred with the spleen cells. The first group of donors provided a
high level of DTH during the period of cell proliferation when specifically
sensitized cells are vinblastine sensitive. They had been treated with CY 2 days
before intravenous immunization with 108 SRBC . When transfer was performed
on day 5 of the response the donors gave a mean DTH reaction of 10 .4 . The
second group of donors had been treated with CY and sensitized concurrently
with a foot pad inoculum of 108 SRBC . Spleen cells from these donors were
transferred 14 days later when vinblastine sensitivity had passed and the level of
DTH had fallen to 9.8. The levels of DTH measured in recipients of one spleen
equivalent (about 1 x 108 cells) are recorded in Fig. 8. They show that the DTH
conferred by replicating and resting cells decayed at comparable rates, and
provide strong presumptive evidence that the early and later mediators of DTH92
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are lineally related. In this experiment, the apparent half-lives of the reactive
cells were longer (about 45 days) than in the previous experiment in which the
influence of BCG may have been transmitted to the recipients .
Susceptibility to Blocking by Immune Complexes. In the experiment re-
corded in Fig. 6, two groups of recipients of the spleen cells harvested on days 4
and 15 were treated with blocking serum. This was prepared by absorbing
immune serum with an equal volume of packed SRBC (20). The absorbed 4-day
serum (AS4), 0.2 ml of which was given to recipients 1 h before cell transfer,
completely abolished DTH in recipients of 4-day immune spleen cells, but was
only partially inhibitory for cells harvested on day 15. More significant still was
the finding (Fig. 7) that the sensitized cells harvested on day 5 from the
BCG/CY-treated donors were also highly resistant to blocking by AS4.
Discussion
Following the precedent of Raff and Cantor (26), the following convention will be
used to designate the specific mediators of DTH: The post-thymic precursors of
specifically committed lymphocytes will be called T2 cells; the vinblastine-sensi-
tive cells which are found during the proliferative phase of the immune response,
and which are so readily inhibited by blocking serum (Fig. 6), will be called T3
cells; while the vinblastine-resistant. cells that come later in the immune
response, and are relatively resistant to blocking, will be called T4 cells.
The present studies have shown (Fig. 1) that an unmodulated response to
SRBC generated little of the T-cell activity represented by DTH. Moreover, the
low level of T4-mediated DTH that did result from the most effective dose of
SRBC (104) could not be built upon by further antigenic stimulation at the same
dose level (Fig. 2 A) . It was also quite unstable in that a larger dose of antigen
extinguished all remaining DTH (Fig. 2 B) . It seemed as though all ofthe T4 cells
created by the primary response had been consumed, perhaps in helper function,
during the secondary response. Some findings seemed to support this explana-
tion, for when the general level of T-cell activity was raised to a much higher
plane by immunizing under the modulating influences of CY (Fig. 3 A) or BCG
(Fig. 3 B), DTH was not abolished by a secondary antigenic stimulus of the same
magnitude. There was, however, a very notable difference between the secondary
responses given by mice in whom the primary responses had been modulated by
CY or BCG. In the former the secondary T-cell response was apparently still
susceptible to feedback inhibition (Fig. 3 A), an impression that was confirmed
by the fact that CY had the same potentiating effect on the T-cell response
during secondary antigenic stimulation (Fig. 5 A) as it has during a primary
response (15). In BCG-modulated immunity, on the other hand, the secondary
T-cell response was apparently protected against feedback inhibition (Fig. 3 B)
and could not be potentiated by treating with CY at the time of the secondary
antigenic stimulus (Fig. 5 B).
It seemed certain that the observed freedom of BCG-modulated immunity to
give an uninhibited secondary T-cell response was not due directly to any
persisting effect of active infection with BCG because previous studies had shown
that the modulating influence of BCG on a primary response had largelyP. H. LAGRANGE AND G. B. MACKANESS
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disappeared within 6 wk (16), yet animals immunized under the modulating
influence of BCG plus CY responded to secondary immunization at 16 wk as well
as they did at 3 wk (Fig . 4) . It should be noted, too, that control mice which had
not received the primary antigenic stimulus but had been infected with BCG for
5 wk showed only a minor degree of potentiated T-cell activity when given SRBC
at the time of the secondary challenge in the experiment recorded in Fig. 3 B.
Evidently the capacity of the primed mice to give an exaggerated secondary
T-cell response was due to conditions that originated during the primary
response, as modulated by BCG.
There are two possible reasons for the abnormal immunological responsiveness
of mice with BCG-modulated immunity : either their T4 cells are different or they
exist in an altered environment. In either case, the findings seem to explain why a
tuberculin test causes enhancement of tuberculin sensitivity (27), even though
tuberculin cannot induce tuberculin sensitivity in the first place; and why
repeated skin testing should raise the level of hypersensitivity after BCG
vaccination in man (28) . These observations suggest that T4 cells may differ from
T2's, their uninduced precursors, in being more easily engaged by antigen. This,
however, would not explain the difference between the secondary responses in
BCG- and CY-modulated immunity. Nor, would it explain why the T3 cells
produced under the combined influence of BCG and CY were so resistant to
blocking by AS4 (Fig. 7) while those formed under the influence of CY alone were
completely inhibited by it (Fig. 6) . Resistance of activated T cells to blocking by
immune complexes no doubt explains why BCG-modulated immunity is not
susceptible to feedback inhibition (Figs. 3 B and 5 B) and provides an alternative
explanation for the previously reported finding that activated T cells formed
under the influence of a BCG infection are resistant to specific blocking serum
(16) . Unfortunately, the present observations do not indicate whether the cells
themselves are physiologically different, or whether they merely behave differ-
ently because of conditions created when a primary immune response is enacted
in the presence of a BCG infection.
Since the production and function of activated T cells is largely governed by
the humoral response (20), the stability of BCG-modulated immunity may
depend upon the nature of the humoral response that accompanies it. It has long
been known, for example, that FCA favors -y,-antibody production (29, 30) . It
may be, therefore, that the antibody produced in a BCG-modulated response is
predominantly of a type that cannot form the complexes which block T cells (20) .
Alternatively, the antibody formed during the secondary response in BCG-
modulated immunity might quickly inhibit IgM production (31) . And since the
complexes formed with IgM have a powerful blocking effect on T3 cells
(unpublished results), this could delay the shutdown of the T-cell response and
cause the observed rise in the level of T-cell activity after a secondary stimulus
(Fig . 4) .
This explanation is not consistent, however, with the results of Fig. 7 which
show that T3 cells may be resistant to passively administered blocking serum.
Since the cell donors in this experiment were treated with CY 2 days before
immunization, they would have suffered a delay in the onset of antibody
production . But at the time when spleens were taken (day 5) antibody production94
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could already have resumed and may have included a class of antibody with the
ability to cause "unblocking" (32). These are important questions but they will
remain unanswered until more studies have been performed.
The correlation observed by Coe et al. (13) between the content of large
lymphocytes in thoracic duct lymph and the capacity ofits cells to transferDTH
makes it likely that specifically sensitized lymphocytes were still being actively
formed at the time chosen by these authors to observe the traffic of specifically
reactive cells in central lymph. The protracted survival of functionally active
mediator cells in syngeneic recipients (Fig. 8) makes it certain, however, that
DTH can persist for an extended period without constant renewal of the
mediators. Nevertheless, a discrepancy was noted in the rate of decay of DTH in
syngeneic recipients ofimmune spleen cells. In one case, a half'-life of34 days was
computed; in two others it was rather longer (45-50 days). In an unreported
experiment, mice sensitized under the influence of BCG and CY were followed for
a period of 24 wk without retesting. DTH persisted in them witha half-life of 35
wk. There is, therefore, a possibility that the state of DTH, like that of antibody
formation (33), may be driven by residual antigen; and that antigen can be
carried into recipients with the spleen cells used for adoptive immunization. This
does not contradict the evidence indicating that specifically sensitized lympho-
cytes have a long life-span which seems to be comparable with that of the
long-lived memory cells of rats (34).
Summary
An antigen dose below the level needed to provoke an antibody response produces
in mice a persistent, but minor degree of delayed-type hypersensitivity (DTH) to
sheep red blood cells. The DTH is unstable. It is erased by larger doses of antigen
and cannot be built upon by further antigenic stimulation. The much higher
levels of DTH resulting from immunization under the modulating influence of
cyclophosphamide (CY) or BCG persist under strong secondary antigenic
stimulation, though the former is subject to partial suppression unless CY is used
to prevent the secondary humoral response. The DTH produced by a BCG-
modulated primary response is not subject to this suppressive effect of a
secondary antibody response. In this case the anamnestic T-cell response is very
brisk and cannot be potentiated by giving CY at the time of the secondary
antigenic stimulus. This effect is not due to the modulating influence of a
residual BCG infection. It results from a permanent change induced during the
primary response .
The mediator cells formed under the influence of BCG are apparently resistant
to inhibition by blockingserum containing immune complexes. Even the actively
dividing T cells which are susceptible to vinblastine, and most readily blocked in
the absence of BCG, are highly resistant to blocking by immune complexes. It is
not clear whether these cells are intrinsically different or whether their
insensitivity to blocking results from features peculiar to the humoral response
that accompanies a BCG-modulated primary response. The mediator cells
produced by both BCG- and CY-modulated responses become vinblastineresistant, relatively insensitive to humoral blocking factors, and capable of
surviving in a functionally active form in syngeneic recipients with an appar-
ent half-life of about 50 days. There were indications, however, that their effec-
tive life-span may be greatly extended in some circumstances by persisting anti-
genic stimulation ; and in the case of BCG-modulated immunity the prevailing
level of T-cell activity can be greatly augmented by a further antigenic stimulus
without the necessity for renewed exposure to BCG .
Receiued for publication 16 September 1974.
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